m (corrected minor grammar mistakes (got replaced with was, and used some more scientific words)) |
m (further Grammar Changes) |
||
Line 4: | Line 4: | ||
in soil. It can form a protective endospore to resist extreme environmental conditions. | in soil. It can form a protective endospore to resist extreme environmental conditions. | ||
− | We decided to work | + | We decided to work with this organism, because ''Bacillus subtilis'' is a bacteria, which naturally secretes proteins |
and enzymes into its surrounding medium. <br /> | and enzymes into its surrounding medium. <br /> | ||
The goal was to utilise this attribute for enzyme production and create a “cell factory”. Instead of | The goal was to utilise this attribute for enzyme production and create a “cell factory”. Instead of | ||
lysating bacteria, it was desired to have a continuous production of enzymes in a liquid culture that | lysating bacteria, it was desired to have a continuous production of enzymes in a liquid culture that | ||
we can extract from the supernatant. <br /> | we can extract from the supernatant. <br /> | ||
− | Repeated inoculations of new bacteria cultures are not necessary because they will stay in the | + | Repeated inoculations of new bacteria cultures are not necessary, because they will stay in the |
stationary phase. Only the media has to be replaced. | stationary phase. Only the media has to be replaced. | ||
''Bacillus subtilis'' is classified as a GRAS-organism (general regarded as safe) by the U. S. Food & | ''Bacillus subtilis'' is classified as a GRAS-organism (general regarded as safe) by the U. S. Food & | ||
− | Drug | + | Drug administration and widely used in S1 laboratories as a model organism. It is also present in |
economy as probiotics in pharmacies or fungicide in agriculture. <br /> | economy as probiotics in pharmacies or fungicide in agriculture. <br /> | ||
− | Furthermore biotechnological applications already | + | Furthermore biotechnological applications already use ''Bacillus subtilis'' to synthesize enzymes. |
=== Usage === | === Usage === | ||
Line 21: | Line 21: | ||
Either just using the supernatant to deink our paper fibers or make the time intensive and expensive | Either just using the supernatant to deink our paper fibers or make the time intensive and expensive | ||
step of purifying our enzymes and then proceed with deinking the paper. For purification we | step of purifying our enzymes and then proceed with deinking the paper. For purification we | ||
− | attached a His-tag | + | attached a His-tag to our enzymes to separate them from other components of the supernatant |
with nickel columns. | with nickel columns. | ||
Line 28: | Line 28: | ||
We worked with two different ''Bacillus subtilis'' strains which were donated by the department of | We worked with two different ''Bacillus subtilis'' strains which were donated by the department of | ||
Pharmaceutical Biotechnology of the Greifswald University, Germany. <br /> | Pharmaceutical Biotechnology of the Greifswald University, Germany. <br /> | ||
− | We got the wild type strain ATCC 6051 | + | We got the wild type strain ATCC 6051 as well as the promising LS8P-D strain. The LS8P-D stain |
is a derivate from the protease-deficient WB800 strain, where two additionally genes were deleted. | is a derivate from the protease-deficient WB800 strain, where two additionally genes were deleted. | ||
The lack of proteases is essential to secrete our enzymes without damaging them. <br /> | The lack of proteases is essential to secrete our enzymes without damaging them. <br /> | ||
− | After trying out multiple protocols we decided to accomplish transformation by electroporation. | + | After trying out multiple protocols, we decided to accomplish transformation by electroporation. |
The principle of electroporation relies on creating small holes in the cell wall of bacteria, by | The principle of electroporation relies on creating small holes in the cell wall of bacteria, by | ||
sending a current through them. The plasmids enter the bacteria through the holes before the | sending a current through them. The plasmids enter the bacteria through the holes before the | ||
Line 38: | Line 38: | ||
The iGEM Team Freiburg and the iGEM Team Bonn collaborated in order to obtain working | The iGEM Team Freiburg and the iGEM Team Bonn collaborated in order to obtain working | ||
transformation protocols for Bacillus subtilis. The resulting manual “How to ''Bacillus subtilis''” can | transformation protocols for Bacillus subtilis. The resulting manual “How to ''Bacillus subtilis''” can | ||
− | be found on our | + | be found on our site: |
<html><a class="btn btn-default" href="//2016.igem.org/Team:UBonn_HBRS/Collaborations">Collaborations Page</a></html> | <html><a class="btn btn-default" href="//2016.igem.org/Team:UBonn_HBRS/Collaborations">Collaborations Page</a></html> | ||
Line 45: | Line 45: | ||
=== Protocol Part === | === Protocol Part === | ||
To acquire electrocompetent ''Bacillus subtilis'', the bacteria had to be cultivated overnight in LB | To acquire electrocompetent ''Bacillus subtilis'', the bacteria had to be cultivated overnight in LB | ||
− | medium. 500 μl of the preculture were added to each of the | + | medium. 500 μl of the preculture were added to each of the 3 flasks containing 20ml of competency medium (LB |
medium containing 0.5M Sorbitol) and the cultures were incubated at 37°C 250 rpm shaking till a | medium containing 0.5M Sorbitol) and the cultures were incubated at 37°C 250 rpm shaking till a | ||
OD600nm between 0.5 and 0.7/ml was reached. Glycine was added as a weakening agent, replacing | OD600nm between 0.5 and 0.7/ml was reached. Glycine was added as a weakening agent, replacing | ||
Line 59: | Line 59: | ||
Glycine is supposed to act as a weakening agent, by replacing the alanine in the cell wall and | Glycine is supposed to act as a weakening agent, by replacing the alanine in the cell wall and | ||
thereby loosening it 2. <br /> | thereby loosening it 2. <br /> | ||
− | Electroporation worked best with a higher glycine concentration. | + | Electroporation worked best with a higher glycine concentration. However a too high concentration |
prevents bacterial growth and could also be toxic. The highest colony number was | prevents bacterial growth and could also be toxic. The highest colony number was | ||
measured by using a mixture of all three glycine concentrations (1%,1.25% and 1.5%) for the | measured by using a mixture of all three glycine concentrations (1%,1.25% and 1.5%) for the | ||
Line 65: | Line 65: | ||
− | In order to transform the microorganisms an electroporator was used with the fitting cuvettes. | + | In order to transform the microorganisms, an electroporator was used with the fitting cuvettes. |
For the electroporation a mix out of plasmid DNA and competent bacteria was prepared with a volume of | For the electroporation a mix out of plasmid DNA and competent bacteria was prepared with a volume of | ||
60 μl containing 10ng of DNA per μl. The mixture was cooled on ice for 10 min along with the | 60 μl containing 10ng of DNA per μl. The mixture was cooled on ice for 10 min along with the |
Revision as of 14:54, 19 October 2016
B. Subtilis
General
Bacillus subtilis is a gram-positive bacterium which can be found almost everywhere, especially in soil. It can form a protective endospore to resist extreme environmental conditions.
We decided to work with this organism, because Bacillus subtilis is a bacteria, which naturally secretes proteins
and enzymes into its surrounding medium.
The goal was to utilise this attribute for enzyme production and create a “cell factory”. Instead of
lysating bacteria, it was desired to have a continuous production of enzymes in a liquid culture that
we can extract from the supernatant.
Repeated inoculations of new bacteria cultures are not necessary, because they will stay in the
stationary phase. Only the media has to be replaced.
Bacillus subtilis is classified as a GRAS-organism (general regarded as safe) by the U. S. Food &
Drug administration and widely used in S1 laboratories as a model organism. It is also present in
economy as probiotics in pharmacies or fungicide in agriculture.
Furthermore biotechnological applications already use Bacillus subtilis to synthesize enzymes.
Usage
For using our product we currently have two different approaches.
Either just using the supernatant to deink our paper fibers or make the time intensive and expensive
step of purifying our enzymes and then proceed with deinking the paper. For purification we
attached a His-tag to our enzymes to separate them from other components of the supernatant
with nickel columns.
In order to reach the project goals plasmids containing the needed genes had to be transformed into
the bacteria.
We worked with two different Bacillus subtilis strains which were donated by the department of
Pharmaceutical Biotechnology of the Greifswald University, Germany.
We got the wild type strain ATCC 6051 as well as the promising LS8P-D strain. The LS8P-D stain
is a derivate from the protease-deficient WB800 strain, where two additionally genes were deleted.
The lack of proteases is essential to secrete our enzymes without damaging them.
After trying out multiple protocols, we decided to accomplish transformation by electroporation.
The principle of electroporation relies on creating small holes in the cell wall of bacteria, by
sending a current through them. The plasmids enter the bacteria through the holes before the
organism repairs them.
The iGEM Team Freiburg and the iGEM Team Bonn collaborated in order to obtain working transformation protocols for Bacillus subtilis. The resulting manual “How to Bacillus subtilis” can be found on our site:
Protocol Part
To acquire electrocompetent Bacillus subtilis, the bacteria had to be cultivated overnight in LB medium. 500 μl of the preculture were added to each of the 3 flasks containing 20ml of competency medium (LB medium containing 0.5M Sorbitol) and the cultures were incubated at 37°C 250 rpm shaking till a OD600nm between 0.5 and 0.7/ml was reached. Glycine was added as a weakening agent, replacing the alanine in the cell wall leading to loosen it, for total concentrations of 1%, 1,25% and 1,5% in the different flasks. This was followed by a 60min incubation. The cells were cooled on ice for 15min and were pelleted by centrifuging at 8500 rpm for 10min at 4°C. The supernatant was removed and the cell pellet was washed repeatedly through a circle of resuspending, pelleting and discarding of supernatant. The washing steps were performed with washing buffer (0.5M Sorbitol, 0.5M Mannitol and 10% Glycerol). Finally all pellets were combined and resuspended in washing buffer. Aliquots were made and were frozen in liquid nitrogen before being stored at -80°C.
In order to transform the microorganisms, an electroporator was used with the fitting cuvettes.
For the electroporation a mix out of plasmid DNA and competent bacteria was prepared with a volume of
60 μl containing 10ng of DNA per μl. The mixture was cooled on ice for 10 min along with the
electroporation cuvette and was electroporated at 2,1 kV. 1 ml of competency medium was
used to flush the cells out of the cuvette and the culture was incubated at 37°C 250 rpm shacking for
about 3h before it was plated on LB agar containing kanamycin.
1: http://www.fda.gov/Food/IngredientsPackagingLabeling/GRAS/
2: Zhi Zhang et al.: Development of an Efficient Electroporation Method for Iturin A-Producing Bacillus subtilis ZK